Immunocytochemical staining of breast carcinoma with the monoclonal antibody NCRC 11: a new prognostic indicator. 1985

I O Ellis, and C P Hinton, and J MacNay, and C W Elston, and A Robins, and A A Owainati, and R W Blamey, and R W Baldwin, and B Ferry

The staining of breast cancer with a new monoclonal antibody, NCRC 11, was studied in a series of 126 women with primary breast carcinoma. Tumour samples embedded in paraffin were tested, and the minimum duration of follow up was five years or to death. Altogether 119 tumours stained positively. There was a strong relation between the intensity of staining, divided on a four point scale, and patient survival. Patients whose tumours exhibited intense staining had an improved survival compared with those with less intensely staining tumours (p less than 0.0001). Staining related weakly to histological grade but not significantly to oestrogen receptor state or the pathological stage of lymph node disease. Mathematical analysis showed the relation to survival to be independent of the other known prognostic factors. Inclusion of intensity of staining with other factors in a prognostic index might permit a more accurate estimation of prognosis in patients with breast cancer.

UI MeSH Term Description Entries
D007120 Immunochemistry Field of chemistry that pertains to immunological phenomena and the study of chemical reactions related to antigen stimulation of tissues. It includes physicochemical interactions between antigens and antibodies.
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

I O Ellis, and C P Hinton, and J MacNay, and C W Elston, and A Robins, and A A Owainati, and R W Blamey, and R W Baldwin, and B Ferry
December 1988, Histopathology,
I O Ellis, and C P Hinton, and J MacNay, and C W Elston, and A Robins, and A A Owainati, and R W Blamey, and R W Baldwin, and B Ferry
September 1987, British journal of cancer,
I O Ellis, and C P Hinton, and J MacNay, and C W Elston, and A Robins, and A A Owainati, and R W Blamey, and R W Baldwin, and B Ferry
July 1991, British journal of cancer,
I O Ellis, and C P Hinton, and J MacNay, and C W Elston, and A Robins, and A A Owainati, and R W Blamey, and R W Baldwin, and B Ferry
May 1984, Histopathology,
I O Ellis, and C P Hinton, and J MacNay, and C W Elston, and A Robins, and A A Owainati, and R W Blamey, and R W Baldwin, and B Ferry
January 1987, Archiv fur Geschwulstforschung,
I O Ellis, and C P Hinton, and J MacNay, and C W Elston, and A Robins, and A A Owainati, and R W Blamey, and R W Baldwin, and B Ferry
April 1996, Acta histochemica,
I O Ellis, and C P Hinton, and J MacNay, and C W Elston, and A Robins, and A A Owainati, and R W Blamey, and R W Baldwin, and B Ferry
September 1986, British journal of cancer,
I O Ellis, and C P Hinton, and J MacNay, and C W Elston, and A Robins, and A A Owainati, and R W Blamey, and R W Baldwin, and B Ferry
November 1987, Histopathology,
I O Ellis, and C P Hinton, and J MacNay, and C W Elston, and A Robins, and A A Owainati, and R W Blamey, and R W Baldwin, and B Ferry
January 1990, Cancer immunology, immunotherapy : CII,
I O Ellis, and C P Hinton, and J MacNay, and C W Elston, and A Robins, and A A Owainati, and R W Blamey, and R W Baldwin, and B Ferry
January 1992, Cytopathology : official journal of the British Society for Clinical Cytology,
Copied contents to your clipboard!